HC Wainwright maintains $25 price target on Solid Biosciences
HC Wainwright & Co. maintained a $25.00-per-share price target for Solid Biosciences, citing a ratings action
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.